UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 29, 2016
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
|
UTAH
|
87‑0342734
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
|
Registrant's telephone number:
|
(801) 566‑1200
|
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On April 29, 2016 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:
|
Elected Barbara A. Payne as a director of the Company:
|
|||||||
|
For
|
1,783,768
|
Withheld
|
1,229,992
|
Broker Non Votes
|
440,435
|
||
|
Ratified the selection of Jones, Simkins P.C. as the Company's independent public accounting firm for the year ended December 31, 2016:
|
|||||||
|
For
|
3,385,304
|
Against
|
56,151
|
Abstentions
|
12,740
|
||
|
Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
|
|||||||
|
For
|
2,981,201
|
Against
|
25,510
|
Abstentions
|
7,049
|
Broker Non Votes 440,435
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
UTAH MEDICAL PRODUCTS, INC.
|
|
|
REGISTRANT
|
|
|
Date: 5/02/2016
|
By: /s/ Kevin L. Cornwell |
|
Kevin L. Cornwell
|
|
|
CEO
|